首页> 外文期刊>Breast Cancer >Catechol-O-methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria
【24h】

Catechol-O-methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria

机译:儿茶酚-O-甲基转移酶Val 108/158 Met多态性与乳腺癌风险:叙利亚的病例对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background Catechol-O-methyltransferase (COMT) inactivates catechol estrogens by methylation and thus may play a protective role against mutations induced by estrogen metabolites. In this study we investigated the relationship between the Vall58Met polymorphism in the COMT gene and breast cancer risk in a population-based case control study in Syria.
机译:背景儿茶酚-O-甲基转移酶(COMT)通过甲基化使儿茶酚雌激素失活,因此可能对由雌激素代谢物引起的突变起保护作用。在这项研究中,我们在叙利亚一项基于人群的病例对照研究中,研究了COMT基因中Vall58Met多态性与乳腺癌风险之间的关系。

著录项

  • 来源
    《Breast Cancer》 |2013年第1期|62-66|共5页
  • 作者单位

    Department of Pharmacology Cancer Research Lab Faculty of Pharmacy University of Aleppo">(1);

    Department of Pharmacology Cancer Research Lab Faculty of Pharmacy University of Aleppo">(1);

    Pathology Department Faculty of Medicine University of Aleppo">(2);

    Oncosurgery Ibn Rushd Hospital">(3);

    Department of Pharmacology Cancer Research Lab Faculty of Pharmacy University of Aleppo">(1);

    Research Cancer Centre of the Syrian Society Against Cancer">(4);

    Oncology Department Faculty of Medicine McGill University">(5);

    Department of Pharmacology Cancer Research Lab Faculty of Pharmacy University of Aleppo">(1);

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Breast cancer; Syrian patients; COMT; Val158Met; Polymorphism;

    机译:乳腺癌;叙利亚病人;COMT;Val158Met;多态性;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号